middle.news
Island takes Galidesivir from regulatory planning to Uganda and Marburg execution
9:40am on Monday 26th of October, 2026 AEDT
•
Biotechnology and Pharmaceuticals
Read Story
Island takes Galidesivir from regulatory planning to Uganda and Marburg execution
9:40am on Monday 26th of October, 2026 AEDT
Key Points
Uganda approvals secured for compassionate Galidesivir use under the WHO MEURI framework
Marburg dose optimisation program expanded to 32 non-human primates across USAMRIID and Texas Biomed
First 5kg GMP API batch targeted for completion by end-October, with 700-800 treatment courses planned
Singapore patent granted for ISLA-101 use against flavivirus and Chikungunya infections
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE